相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Myelin Measurement Using Quantitative Magnetic Resonance Imaging: A Correlation Study Comparing Various Imaging Techniques in Patients with Multiple Sclerosis
Laetitia Saccenti et al.
CELLS (2020)
Emerging myelin repair agents in preclinical and early clinical development for the treatment of multiple sclerosis
Stefan Gingele et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study
Tjalf Ziemssen et al.
CNS DRUGS (2020)
Imaging the multiple sclerosis lesion: insights into pathogenesis, progression and repair
Chenyu Tim Wang et al.
CURRENT OPINION IN NEUROLOGY (2019)
Lesion activity and chronic demyelination are the major determinants of brain atrophy in MS
Chenyu Wang et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)
The electrophysiological assessment of visual function in Multiple Sclerosis
Joshua L. Barton et al.
CLINICAL NEUROPHYSIOLOGY PRACTICE (2019)
White matter tract-specific quantitative analysis in multiple sclerosis: Comparison of optic radiation reconstruction techniques
Chenyu Wang et al.
PLOS ONE (2018)
Evidence of progressive tissue loss in the core of chronic MS lesions: A longitudinal DTI study
Alexander Klistorner et al.
NEUROIMAGE-CLINICAL (2018)
Assessment of Opicinumab in Acute Optic Neuritis Using Multifocal Visual Evoked Potential
Alexander Klistorner et al.
CNS DRUGS (2018)
Test-Retest Reliability and Concurrent Validity of in Vivo Myelin Content Indices: Myelin Water Fraction and Calibrated T1w/T2w Image Ratio
Muzamil Arshad et al.
HUMAN BRAIN MAPPING (2017)
A Comparison of Magnetization Transfer Methods to Assess Brain and Cervical Cord Microstructure in Multiple Sclerosis
Alfonso Lema et al.
JOURNAL OF NEUROIMAGING (2017)
Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial
Ari J. Green et al.
LANCET (2017)
Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial
Diego Cadavid et al.
LANCET NEUROLOGY (2017)
Alemtuzumab CARE-MS I 5-year follow-up Durable efficacy in the absence of continuous MS therapy
Eva Havrdova et al.
NEUROLOGY (2017)
Can immune reprogramming with alemtuzumab induce permanent remission in multiple sclerosis?
Heinz Wiendl et al.
NEUROLOGY (2017)
Alemtuzumab CARE-MS II 5-year follow-up
Alasdair J. Coles et al.
NEUROLOGY (2017)
TUMEFACTIVE DEMYELINATION FOLLOWING TREATMENT FOR RELAPSING MULTIPLE SCLEROSIS WITH ALEMTUZUMAB
Joshua Barton et al.
NEUROLOGY (2017)
Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials
Maria Pia Sormani et al.
NEUROTHERAPEUTICS (2017)
Axonal damage in central and peripheral nervous system inflammatory demyelinating diseases: common and divergent pathways of tissue damage
Michael H. Barnett et al.
CURRENT OPINION IN NEUROLOGY (2016)
Multifocal Visual Evoked Potential (mfVEP) and Pattern-Reversal Visual Evoked Potential Changes in Patients with Visual Pathway Disorders: A Case Series
Daniah Alshowaeir et al.
NEURO-OPHTHALMOLOGY (2015)
Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis
Ernst-Wilhelm Radue et al.
NEUROLOGY (2015)
Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy
Orla Tuohy et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Decoding Diffusivity in Multiple Sclerosis: Analysis of Optic Radiation Lesional and Non-Lesional White Matter
Alexander Klistorner et al.
PLOS ONE (2015)
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis
Nicola De Stefano et al.
CNS DRUGS (2014)
Imaging outcomes for trials of remyelination in multiple sclerosis
Shahrukh Mallik et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Brain atrophy and lesion load predict long term disability in multiple sclerosis
Veronica Popescu et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Evaluating and reducing the impact of white matter lesions on brain volume measurements
Marco Battaglini et al.
HUMAN BRAIN MAPPING (2012)
Rapid whole cerebrum myelin water imaging using a 3D GRASE sequence
Thomas Prasloski et al.
NEUROIMAGE (2012)
Overcoming remyelination failure in multiple sclerosis and other myelin disorders
Stephen P. J. Fancy et al.
EXPERIMENTAL NEUROLOGY (2010)
Thalamic Damage and Long-term Progression of Disability in Multiple Sclerosis
Maria Assunta Rocca et al.
RADIOLOGY (2010)
Effects of commissural de- and remyelination on motor skill behaviour in the cuprizone mouse model of multiple sclerosis
David Liebetanz et al.
EXPERIMENTAL NEUROLOGY (2006)
Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water
SK Song et al.
NEUROIMAGE (2002)
Accurate, robust, and automated longitudinal and cross-sectional brain change analysis
SM Smith et al.
NEUROIMAGE (2002)
分享论文
